Tests

1st tests to order

endoscopy

Test
Result
Test

All patients should undergo esophagogastroduodenoscopy (EGD), colonoscopy, and video capsule endoscopy (VCE) or computed tomography/magnetic resonance enterography (CTE or MRE), starting by age 8 years (and earlier in those with symptoms).[17][18][22]​​​​[27][28][30]​​​​​​ Capsule endoscopy is safe to use in individuals with Peutz-Jeghers syndrome and small bowel polyposis who lack obstructive symptoms. If a concern for capsule retention is present, a patency capsule should be utilized. In general, adverse events associated with diagnostic EGD are rare (reported rates: infection <0.3%, bleeding <0.1%, cardiopulmonary events <0.1%, perforation <0.01%).[29]

Gastric, small bowel, and colorectal polyposis occur in 88% to 100% of patients, with the majority appearing in the small bowel (60% to 90%) and colon (50% to 64%).[18]

In rare cases, polyps have also occurred in the renal pelvis, urinary bladder, lungs, and nares.

Multiple polyps are typical; usually the total number is <20. Individual polyps vary in size from a few millimeters to several centimeters.

Result

intestinal polyps of variable number

magnetic resonance enterography

Test
Result
Test

All patients should undergo esophagogastroduodenoscopy (EGD), colonoscopy, and video capsule endoscopy (VCE) or computed tomography/magnetic resonance enterography (CTE or MRE), starting by age 8 years (and earlier in those with symptoms).[17][18][22]​​[27][28][30]​​

Gastric, small bowel, and colorectal polyposis occur in 88% to 100% of patients, with the majority appearing in the small bowel (60% to 90%) and colon (50% to 64%).[18]

In rare cases, polyps have also occurred in the renal pelvis, urinary bladder, lungs, and nares.

Multiple polyps are typical; usually the total number is <20. Individual polyps vary in size from a few millimeters to several centimeters.

Result

intestinal polyps of variable number

polyp histology

Test
Result
Test

Polyp histology is used to guide diagnosis and genetic testing.[15]

Polyps may be small or large, sessile or pedunculated. They often have a characteristic cerebriform appearance due to smooth muscle arborization within the polyps. Pathologically, Peutz-Jeghers polyps are unique in that there is an overgrowth of the muscularis mucosae, apparent as arborizing bundles of smooth muscle underlying the epithelium. This smooth muscle core is covered by lamina propria and mature glandular epithelium. [Figure caption and citation for the preceding image starts]: Histology of a hamartomatous polypFrom the collection of Dr Carol A. Burke, used with permission [Citation ends].com.bmj.content.model.Caption@5c314634

When determining diagnosis or genetic testing strategy, polyps should be reviewed by a dedicated gastrointestinal pathologist, as significant discrepancies have been identified when hamartomatous polyps are re-reviewed.[31]

Result

hamartomatous polyp

STK11 genetic testing

Test
Result
Test

Germline genetic testing (performed on a blood sample) should be utilized to confirm the clinical diagnosis in those patients who satisfy the diagnostic criteria for Peutz-Jeghers syndrome (PJS).[18] Sequencing of STK11 will detect 30% to 69% of mutations, and deletion/duplication analysis will find another 30% of germline alterations.[16][23][24]​​ Multigene panel testing is the preferred method for genetic testing for PJS.[18]​ Detection of a pathogenic variant confirms the diagnosis. A negative result significantly reduces the likelihood that the patient has PJS, although pathogenic variants may be missed. A variant mutation of uncertain significance (VUS) could also be identified.

If a patient has a negative or VUS result on genetic testing and meets the clinical criteria, they should be managed as though they have PJS, or evaluated further for another genetic syndrome.[18]​ Repeated genetic testing is generally unneeded unless there is uncertainty about an existing result: for example, the result is inconsistent with the patient’s clinical presentation or the test methodology has changed or significantly advanced.[25][26]

Result

positive for a deleterious mutation

Use of this content is subject to our disclaimer